Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H E Windschitl

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Archives of Surgery (Chicago, Ill. : 1960)|July 1, 1990
Adjuvant therapy for resectable colorectal carcinoma with fluorouracil administered by portal vein infusion. A study of the Mayo Clinic and the North Central Cancer Treatment GroupR W Beart, C G Moertel, H S Wieand, et al.
Cancer|March 15, 1992
Chemotherapy for hormonally refractory advanced prostate carcinoma. A comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5-fluorouracilJ A Laurie, R G Hahn, T M Therneau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancerC L Loprinzi, S Abu-Ghazaleh, J A Sloan, et al.
American Journal of Clinical Oncology|October 20, 2000
Phase II evaluation of continuous-infusion 5-fluorouracil, leucovorin, mitomycin-C, and oral dipyridamole in advanced measurable pancreatic cancer: a North Central Cancer Treatment Group TrialP A Burch, C Ghosh, G Schroeder, et al.
Cancer|September 1, 1990
A clinical trial of biochemical modulation of 5-fluorouracil with N-phosphonoacetyl-L-aspartate and thymidine in advanced gastric and anaplastic colorectal cancerH E Windschitl, M J O'Connell, H S Wieand, et al.
American Journal of Clinical Oncology|October 16, 1999
Paclitaxel and G-CSF in previously untreated patients with extensive stage small-cell lung cancer: a phase II study of the North Central Cancer Treatment GroupR J Kirschling, J P Grill, R S Marks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1988
Randomized clinical trial of tamoxifen alone or combined with fluoxymesterone in postmenopausal women with metastatic breast cancerJ N Ingle, D I Twito, D J Schaid, et al.
JAMA|April 12, 1985
A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycinS A Cullinan, C G Moertel, T R Fleming, et al.
Cancer|May 15, 1989
Randomized clinical trial of CFP versus CMFP in women with metastatic breast cancerR F Marschke, J N Ingle, D J Schaid, et al.
American Journal of Clinical Oncology|January 22, 2002
A phase II trial of edatrexate, vinblastine, adriamycin, cisplastin, and filgrastim (EVAC/G-CSF) in patients with non-small-cell carcinoma of the lungs: a North Central Cancer Treatment Group TrialG Colon-Otero, R D Niedringhaus, S H Hillman, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Archives of Surgery (Chicago, Ill. : 1960)|July 1, 1990
Adjuvant therapy for resectable colorectal carcinoma with fluorouracil administered by portal vein infusion. A study of the Mayo Clinic and the North Central Cancer Treatment GroupR W Beart, C G Moertel, H S Wieand, et al.
Cancer|March 15, 1992
Chemotherapy for hormonally refractory advanced prostate carcinoma. A comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5-fluorouracilJ A Laurie, R G Hahn, T M Therneau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancerC L Loprinzi, S Abu-Ghazaleh, J A Sloan, et al.
American Journal of Clinical Oncology|October 20, 2000
Phase II evaluation of continuous-infusion 5-fluorouracil, leucovorin, mitomycin-C, and oral dipyridamole in advanced measurable pancreatic cancer: a North Central Cancer Treatment Group TrialP A Burch, C Ghosh, G Schroeder, et al.
Cancer|September 1, 1990
A clinical trial of biochemical modulation of 5-fluorouracil with N-phosphonoacetyl-L-aspartate and thymidine in advanced gastric and anaplastic colorectal cancerH E Windschitl, M J O'Connell, H S Wieand, et al.
American Journal of Clinical Oncology|October 16, 1999
Paclitaxel and G-CSF in previously untreated patients with extensive stage small-cell lung cancer: a phase II study of the North Central Cancer Treatment GroupR J Kirschling, J P Grill, R S Marks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1988
Randomized clinical trial of tamoxifen alone or combined with fluoxymesterone in postmenopausal women with metastatic breast cancerJ N Ingle, D I Twito, D J Schaid, et al.
JAMA|April 12, 1985
A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycinS A Cullinan, C G Moertel, T R Fleming, et al.
Cancer|May 15, 1989
Randomized clinical trial of CFP versus CMFP in women with metastatic breast cancerR F Marschke, J N Ingle, D J Schaid, et al.
American Journal of Clinical Oncology|January 22, 2002
A phase II trial of edatrexate, vinblastine, adriamycin, cisplastin, and filgrastim (EVAC/G-CSF) in patients with non-small-cell carcinoma of the lungs: a North Central Cancer Treatment Group TrialG Colon-Otero, R D Niedringhaus, S H Hillman, et al.
Pageof 3